Chinanews.com, February 1st. On the 1st, Baike Biotechnology issued the "Announcement on the Approval of the Application for the Marketing License of the Voluntary Disclosure of Herpes Zoster Live Attenuated Vaccine". The announcement shows that Changchun Baike Biotechnology Co., Ltd. The "Drug Registration Certificate" of the live attenuated herpes zoster vaccine issued by the Supervision and Administration Bureau.
Previously, only Shingrix produced by GlaxoSmithKline was on the market in China.
Zhongxin Finance noticed that in the delivery information of the drug approval certificate issued by the State Food and Drug Administration on January 31, the approval number of the live attenuated herpes zoster vaccine of Changchun Baike Biotechnology Co., Ltd. is Guoyao Zhunzi S20233097.
(China New Finance and Economics)
Screenshot of the NMPA website.